Loading...
quality

Antibiotic Time-Out at 72 Hours Inspection

Review antibiotic therapy at 72 hours to confirm the indication, align treatment with culture results, and identify safe de-escalation or IV-to-PO opportunities.

Trusted by frontline teams 15 years of frontline software AI customization in seconds

Built for: Healthcare ยท Hospitals ยท Clinical Quality ยท Pharmacy

What's inside this template

Review Context

  • Antibiotic therapy reviewed at approximately 72 hours (critical ยท weight 4.0)
    Verify the review occurred near the 72-hour mark after antibiotic initiation.
  • Indication for antibiotic therapy documented (critical ยท weight 3.0)
    The clinical reason for treatment should be clearly documented.
  • Current antibiotic regimen identified (weight 3.0)
    Confirm the active agent(s), dose, route, and frequency are available for review.
  • Relevant cultures and diagnostic results reviewed (critical ยท weight 5.0)
    Review microbiology, imaging, and other diagnostic data that may affect therapy.

Culture and Susceptibility Review

  • Culture results available (weight 4.0)
    Determine whether culture data are available at the time of review.
  • Organism identified and susceptibilities reviewed when available (critical ยท weight 6.0)
    If cultures are positive, confirm the organism and susceptibility profile were reviewed.
  • Therapy aligned with culture and susceptibility results (critical ยท weight 7.0)
    Verify the regimen matches the identified pathogen and susceptibility data.
  • No growth or contaminant results considered appropriately (weight 4.0)
    Assess whether negative or contaminant results were used to guide therapy decisions.
  • Additional diagnostic data support ongoing infection (weight 4.0)
    Clinical findings, labs, and imaging should support continued treatment if antibiotics are maintained.

Necessity and De-escalation

  • Ongoing need for antibiotics reassessed (critical ยท weight 8.0)
    Confirm the team reassessed whether antimicrobial therapy remains indicated.
  • Opportunity to de-escalate identified (weight 6.0)
    Determine whether broad-spectrum therapy can be narrowed based on current information.
  • Antibiotics discontinued when infection unlikely or ruled out (critical ยท weight 8.0)
    If evidence does not support infection, therapy should be stopped or clearly justified.
  • Planned duration of therapy documented (weight 4.0)
    A target stop date or total duration should be documented when therapy continues.
  • Stewardship recommendation communicated to care team (weight 4.0)
    Confirm recommendations were shared with the prescribing or primary team.

IV-to-PO Conversion Assessment

  • Patient clinically stable for oral therapy (critical ยท weight 6.0)
    Assess hemodynamic stability, improving symptoms, and overall clinical trajectory.
  • Able to tolerate oral intake (critical ยท weight 5.0)
    Confirm the patient can swallow and absorb oral medications.
  • Appropriate oral antibiotic option available (weight 4.0)
    Verify an oral agent with suitable spectrum and bioavailability is available.
  • IV-to-PO conversion recommended (weight 5.0)
    Indicate whether conversion should be made based on the review.

Documentation and Follow-Up

  • Assessment and recommendation documented in chart (critical ยท weight 4.0)
    The 72-hour review should be visible in the medical record.
  • Follow-up plan documented (weight 3.0)
    Include next review timing, lab follow-up, or culture follow-up as needed.
  • Inspector signature (critical ยท weight 3.0)
    Signature of the reviewer completing the audit.

Common use cases

Hospital antibiotic stewardship rounds
72-hour culture review audits
Inpatient IV-to-PO conversion checks
Antibiotic de-escalation documentation
Quality review of empiric therapy

Frequently asked questions

When should this inspection be used?

Use it at about 72 hours after antibiotics are started, when culture and diagnostic results are often available. It helps teams confirm whether therapy still fits the clinical picture and whether changes are needed.

Who should complete the review?

It can be completed by stewardship teams, pharmacists, nurses, or clinicians assigned to audit antibiotic use. The template supports consistent documentation and communication across the care team.

What does the template help identify?

It helps identify whether antibiotics are still necessary, whether therapy should be narrowed, and whether IV-to-PO conversion is appropriate. It also captures when antibiotics should be stopped if infection is unlikely.

Can this template be used when cultures are negative?

Yes. It includes review of no-growth or contaminant results so the reviewer can assess whether ongoing antibiotics are still justified. Additional clinical data can be used to support the decision.

Does it include follow-up documentation?

Yes. The template includes fields for documenting the assessment, recommendation, follow-up plan, and inspector signature. That makes it easier to track stewardship actions in the chart.

Related templates

Ready to use this template?

Get started with MangoApps and use Antibiotic Time-Out at 72 Hours Inspection with your team โ€” pricing built for small business.

Ask AI Product Advisor

Hi! I'm the MangoApps Product Advisor. I can help you with:

  • Understanding our 40+ workplace apps
  • Finding the right solution for your needs
  • Answering questions about pricing and features
  • Pointing you to free tools you can try right now

What would you like to know?